Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
information on ongoing trials is available via the NIHR Be Part of Research service or ClinicalTrials.gov
Most of the tools for managing it are already within reach
Outcomes included change from baseline at week 40 in HbA1c (primary outcome) and bodyweight (secondary confirmatory outcome), evaluated through trial product estimand (no treatment discontinuation or without rescue medication) and treatment policy estimand (regardless of treatment discontinuation or rescue medication) strategies
Used needles should be disposed of in an FDA-cleared sharps container
Your provider will work with you to develop a personalised treatment plan based on your individual needs and goals
